COVID-19 vaccine development: What lessons can we learn from TB?
Abstract At the time of writing, the SARS-CoV-2 virus has infected more than 49 million people causing more than 1.2 million deaths worldwide since its emergence from Wuhan, China in December 2019. Vaccine development against SARS-CoV-2 has drawn the global attention in order to stop the spread of t...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2020-11-01
|
| Col·lecció: | Annals of Clinical Microbiology and Antimicrobials |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12941-020-00402-x |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|